99 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
5 Jun 24
Regulation FD Disclosure
6:04am
statements contained in this press release include, but are not limited to, statements regarding Vir’s strategy and plans, the potential clinical effects
8-K
VIR
Vir Biotechnology Inc
5 Jun 24
Regulation FD Disclosure
6:04am
, but are not limited to, statements regarding the Company’s strategy and plans, the potential clinical effects of tobevibart and elebsiran, the potential
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
financial performance of Vir Biotechnology, Inc. (the “Company” or “Vir”); the Company’s strategy and plans; capital allocation; financial and operating … billion-dollar mergers and acquisitions Served as a member of Bayer’s Executive Committee, and EVP and Global Head of Strategy, BD&L and Open
8-K
EX-99.1
VIR
Vir Biotechnology Inc
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
include, but are not limited to, statements regarding Vir’s strategy and plans; Vir’s cash balance; Vir’s financial guidance; Vir’s future financial
8-K
EX-99.1
137txgib34
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
8-K
EX-99.1
f6mc1sn
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
fy0y i5hwpr0j
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
S-3ASR
0skiiy1b
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
gn133s0ib29tocwy
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
yyn48b1cfwhu8qexxij7
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
tjrek6uow3xp
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
kls2mwk pvgqahjg
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
xhaajz
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am